-
Vaccination is the only long-term solution to COVID-19 crisis in India: Fauci
expresspharma
May 11, 2021
He called for scaling up manufacturing of coronavirus vaccines both domestically and globally to fight the deadly pandemic.
-
More than 78 lakh COVID vaccine doses still available with states and UTs: Centre
expresspharma
May 06, 2021
Implementation of the Liberalised and Accelerated Phase 3 Strategy of COVID-19 vaccination started on Saturday, it informed.
-
India should step up vaccination rate, enable oxygen supplies to control COVID-19 pandemic: GlobalData
expresspharma
April 27, 2021
A novel ‘double mutant’ variant of SARS-CoV-2, along with other factors, has accelerated the COVID-19 pandemic in India, setting a global record of new daily cases.
-
Updated results on coronavirus vaccination effectiveness
worldpharmanews
April 23, 2021
Several weeks following the publication of the large real-world COVID-19 vaccine effectiveness study by the Clalit Research Institute in Collaboration with Harvard University in the New England Journal of Medicine (NEJM), additional results focusing ...
-
Greater risk of brain clots from COVID-19 compared with vaccines: UK researchers
expresspharma
April 19, 2021
The study was based on a US health database, and so did not accrue new data on the risk of clots from AstraZeneca's vaccine directly, as the shot is not being rolled out there.
-
Google commits funds for 250k vaccinations in LMIC
expresspharma
April 16, 2021
Google pledged funds for 250,000 COVID-19 vaccinations and technical assistance towards vaccine delivery in low- and middle-income countries amidst a surge in infections across the world.
-
UK starts administering Moderna vaccine against COVID-19
expresspharma
April 08, 2021
The UK began the rollout of the Moderna vaccine to protect against COVID-19, the third two-dose vaccine now being administered by the National Health Service (NHS) alongside the Pfizer/BioNTech and Oxford/AstraZeneca jabs.
-
Prioritising who receives COVID-19 vaccine first saves lives: Research
expresspharma
April 06, 2021
They found that deaths, years of life lost and infections were between 17 and 44 per cent lower when vaccinations targeted vulnerable populations.
-
Using albumin could facilitate vaccination by inhalation, finds pre-clinical study
europeanpharmaceuticalreview
March 24, 2021
MIT researchers developed and tested in mice intratracheal vaccines to protect against the vaccinia virus and the formation of lung cancer.
-
92 per cent decrease in UK COVID-19 cases since Jan: GlobalData
expresspharma
March 22, 2021
The ending of the national lockdown and the reopening of schools and non-essential industries in April will be a true test of the effectiveness of the vaccinations in limiting the spread of the virus.